Shiinaha, Hindiya
Sidee Baadhista Cilad-sheegashadu u Badbaadinaysaa Nolosha Dagaalada badan ee Myeloma?
Ma jeceshahay sida farsamada caafimaadku u badbaadinayso nolosha bukaanno badan oo myeloma ah? Akhri blog-keena si aad wax badan uga barato farsamadan nolol-badbaadinta! Aynu wada rogno bogga kansarka. Sheekadaada rajadu waxay ka bilaabataa halkan. Jahannamo..
anti-BCMA, BCMA CAR-T, Chimeric antigen receptor T cell therapy, Shiinaha, thrombocytopenia ee difaaca jirka, E.T.C
Ka-hortagga BCMA CAR T-Cell therapy Tijaabooyin caafimaad oo loogu talagalay soo noqoshada/dib u celinta difaaca jirka ee trombocytopenia (R/R ITP)
Maarso 2023: Immune thrombocytopenia (ITP) waa cillad keeni karta nabar iyo dhiig-bax fudud ama xad dhaaf ah. Qiyaastii saddex-meelood laba meel bukaannada ayaa gaadha cafiska ka dib/inta lagu jiro daawaynta safka hore. Si kastaba ha ahaatee, qaybta kale o..
bayotechnoolajiyadda, CAR - T Daaweynta unugyada, GARGAARKA GARGAARKA, Daaweynta CAR, Shiinaha, lacag ururin, Oricell Therapeutics
Oricell waxa uu kor u qaadaa $45M USD si uu ugu balaadhiyo daawaynta CAR T-Cell ee Maraykanka
23rd March 2023: The preclinical and early-stage cancer cell therapies being developed by Shanghai biotech Oricell have received an additional $45 million in funding, the company announced on Tuesday. Following a showing at AS..
Beijing, CARTITUDE-4, CARVYKTI, Shiinaha, ciltacabtagene autoleucel, Tijaabooyinka caafimaadka, Biotech Legend, myeloma badan oo jaban, Shanghai
Legend Biotech wuxuu ku dhawaaqay Wajiga 3 CARTITUDE-4 Daraasadda CARVYKTI®(ciltacabtagene autoleucel) Waxay la kulantay Dhamaadka Dhamaadka Koowaad ee Daawaynta Bukaannada qaba Myeloma-ka-soo-noqoshada iyo dib-u-soo-celinta
JANUARY 27, 2023—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), oo ah shirkad caalami ah oo cilmiga bayoolajiga ah oo horumarinaysa, soo saari doonta, kana ganacsanaysa daawayn cusub oo lagu daweynayo cudurrada nafta halis gelinaya, ayaa maanta lagu dhawaaqay in ..
Beijing, bayotechnoolajiyadda, Daaweynta unugyada, Daaweynta gacanta, Shiinaha, Cilta-Cel, ciltacabtagene autoleucel, Biotech Legend
Legend Biotech wuxuu ku dhawaaqay Aqbalaadda Codsiga Cusub ee Dawada ee Ciltacabtagene Autoleucel (Cilta-Cel) ee Shiinaha
SOMERSET, NJ — JANUARY 2, 2023— Shirkadda Legend Biotech (NASDAQ: LEGN) (Legend Biotech), shirkad caalami ah oo bayoteknoloji ah oo horumarinaysa, soo saari doonta oo ka ganacsanaysa daawayn cusub oo lagu daweeyo cudurrada nafta halis gelinaya, ann..
Shiinaha, Tijaabooyinka caafimaadka, kansarka hepatocellular, Daawooyinka JW, Shanghai
Dawaynta JW waxay ku Dhawaaqday Bilawga Daraasada Kiliinikada ee JWATM214 ee Bukaanada Qaba Hepatocellular Kansarka Sare
SHANGHAI, Shiinaha, Feebarwari 28, 2023 - JW Therapeutics (HKEX: 2126), oo ah shirkad madax-bannaan oo tignoolajiyada casriga ah ee diiradda saaraysa horumarinta, soo saarista iyo ka-ganacsiga alaabada tallaalka unugyada, ayaa ku dhawaaqday bilawga ...
Bulshada Mareykanka ee Cudurka Cudurka Hematology, Carteyva, Shiinaha, Daawooyinka JW, relmacabtagene autoleucel
Dawaynta JW waxay soo bandhigaysaa Xogta Caafimaad ee Ugu Danbaysay ee Carteyva® ee Lymphoma Follicular Lymphoma iyo Mantle Cell Lymphoma kulanka Sannadlaha ah ee 64aad ee ASH
SHANGHAI, CHINA, Diseembar 12, 2022 Shirkad bayotechnoolajiyada madax-bannaan oo hal abuur leh oo la yiraahdo JW Therapeutics (HKEX: 2126) waxay diiradda saartaa horumarinta, soo saarista, iyo iibinta alaabada tallaalka unugyada. Ururka 64-aad ee Maraykanka.
Daaweynta unugyada, Shiinaha, Daawooyinka JW, Shanghai
JW Therapeutics waxay ku dhawaaqday in Dawooyinka Immunotherapy-ga unuggu ay si guul leh uga faa'iideysteen 300 bukaan
SHANGHAI, CHINA, Noofambar 9, 2022 - JW Therapeutics (HKEX: 2126), shirkad madax-bannaan oo tignoolajiyada cusub leh oo diiradda saaraysa horumarinta, soo saarista, iyo ka-ganacsiga alaabada tallaalka unugyada, ayaa ku dhawaaqday in laga bilaabo N..
2 iyo todobaatan bio, Shiinaha, immunotherapy, Daawooyinka JW, Partnership
JW Therapeutics iyo 2 bio ayaa ku dhawaaqay iskaashiga istiraatijiyadeed si loo dardargeliyo cilmi baarista iyo horumarinta daawoyinka difaaca jirka ee T-cell
SHANGHAI, CHINA and CAMBRIDGE, MASSACHUSETTS, US, October 27, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherap..
Shiinaha, Enhertu, HER 2 togan
Enhertu waxaa Shiinaha looga oggolaaday bukaannada qaba kansarka naasaha ee HER2-positive metastatic
Feb 2023: Enhertu (trastuzumab deruxtecan) from AstraZeneca and Daiichi Sankyo has been approved as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received ..